BEAM vs. RXRX
Compare and contrast key facts about Beam Therapeutics Inc. (BEAM) and Recursion Pharmaceuticals, Inc. (RXRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BEAM or RXRX.
Correlation
The correlation between BEAM and RXRX is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BEAM vs. RXRX - Performance Comparison
Key characteristics
BEAM:
-0.31
RXRX:
-0.54
BEAM:
0.04
RXRX:
-0.46
BEAM:
1.00
RXRX:
0.95
BEAM:
-0.26
RXRX:
-0.56
BEAM:
-0.89
RXRX:
-1.54
BEAM:
25.41%
RXRX:
33.02%
BEAM:
74.60%
RXRX:
93.10%
BEAM:
-89.12%
RXRX:
-90.39%
BEAM:
-86.97%
RXRX:
-89.52%
Fundamentals
BEAM:
$1.99B
RXRX:
$2.32B
BEAM:
-$4.58
RXRX:
-$1.80
BEAM:
31.38
RXRX:
39.37
BEAM:
2.72
RXRX:
2.07
BEAM:
$63.58M
RXRX:
$59.76M
BEAM:
$39.61M
RXRX:
-$46.00K
BEAM:
-$285.27M
RXRX:
-$534.16M
Returns By Period
In the year-to-date period, BEAM achieves a -29.80% return, which is significantly higher than RXRX's -35.95% return.
BEAM
-29.80%
6.35%
-35.66%
-22.76%
0.61%
N/A
RXRX
-35.95%
-6.88%
-39.01%
-49.88%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BEAM vs. RXRX — Risk-Adjusted Performance Rank
BEAM
RXRX
BEAM vs. RXRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Beam Therapeutics Inc. (BEAM) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BEAM vs. RXRX - Dividend Comparison
Neither BEAM nor RXRX has paid dividends to shareholders.
Drawdowns
BEAM vs. RXRX - Drawdown Comparison
The maximum BEAM drawdown since its inception was -89.12%, roughly equal to the maximum RXRX drawdown of -90.39%. Use the drawdown chart below to compare losses from any high point for BEAM and RXRX. For additional features, visit the drawdowns tool.
Volatility
BEAM vs. RXRX - Volatility Comparison
The current volatility for Beam Therapeutics Inc. (BEAM) is 30.42%, while Recursion Pharmaceuticals, Inc. (RXRX) has a volatility of 36.48%. This indicates that BEAM experiences smaller price fluctuations and is considered to be less risky than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BEAM vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between Beam Therapeutics Inc. and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities